UTHR insider plans Rule 144 sale of 50 shares

An insider of UTHR has filed a Rule 144 notice to sell 50 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ.

Rhea-AI Filing Summary

An insider of UTHR has filed a Rule 144 notice to sell 50 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ. The filing lists an aggregate market value of $23,711.50 for these shares and shows 43,056,599 shares outstanding.

The shares to be sold were acquired as restricted stock from the issuer on 06/26/2025. Over the past three months, the same seller reported four prior sales of 50 shares each, with gross proceeds of $25,606.00, $24,149.00, $23,049.00, and $24,750.50.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the latest Form 144 filing for UTHR disclose?

The Form 144 filing for UTHR discloses an insider’s intent to sell 50 shares of common stock on NASDAQ. The shares have an aggregate market value of $23,711.50 and were acquired as restricted stock from the issuer on 06/26/2025.

How many UTHR shares are planned to be sold and through which broker?

The filing states that 50 UTHR common shares are planned to be sold. The transaction is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located in New York, with the shares listed for trading on the NASDAQ exchange.

What prior UTHR share sales has this insider reported in the last three months?

Over the last three months, the insider reported four separate sales of 50 UTHR common shares each. These occurred on 12/11/2025, 12/23/2025, 01/06/2026, and 01/20/2026, with gross proceeds ranging from $23,049.00 to $25,606.00.

How many UTHR shares are outstanding according to this Form 144?

The Form 144 indicates that there are 43,056,599 shares of UTHR common stock outstanding. This figure provides context for the planned 50-share Rule 144 sale, showing the relative size of the insider’s transaction compared with total outstanding shares.

How were the UTHR shares in this Form 144 acquired by the insider?

The filing shows the 50 UTHR common shares to be sold were acquired on 06/26/2025 as restricted stock directly from the issuer. The date of payment is also listed as 06/26/2025, and the nature of payment is described as Not Applicable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:03 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002028640
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	UNITED THERAPEUTICS CORPORATION
SEC File Number	000-26301
Address of Issuer	1000 SPRING STREET SILVER SPRING MARYLAND 20910
Phone	(301) 608-9292
Name of Person for Whose Account the Securities are To Be Sold	JAN MALCOLM
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50	23711.50	43056599	02/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/26/2025	Restricted Stock	Issuer			50	06/26/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JAN MALCOLM 1000 SPRING STREET SILVER SPRING MD 20910	Common	12/23/2025	50	25606.00
JAN MALCOLM 1000 SPRING STREET SILVER SPRING MD 20910	Common	12/11/2025	50	24149.00
JAN MALCOLM 1000 SPRING STREET SILVER SPRING MD 20910	Common	01/20/2026	50	23049.00
JAN MALCOLM 1000 SPRING STREET SILVER SPRING MD 20910	Common	01/06/2026	50	24750.50

144: Remarks and Signature

Remarks
Date of Notice	02/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	JAN K. MALCOLM
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)